verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8338
Product ID 68788-8338_c68a7572-2ab6-427e-87a1-a10cbe6c719d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071881
Listing Expiration 2026-12-31
Marketing Start 2023-02-02

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888338
Hyphenated Format 68788-8338

Supplemental Identifiers

RxCUI
897666
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA071881 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (68788-8338-3)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c68a7572-2ab6-427e-87a1-a10cbe6c719d", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666"], "spl_set_id": ["c7a54ee0-80c0-4c7e-a6a3-cb60142f860c"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8338-3)", "package_ndc": "68788-8338-3", "marketing_start_date": "20230202"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "68788-8338_c68a7572-2ab6-427e-87a1-a10cbe6c719d", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68788-8338", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20230202", "listing_expiration_date": "20261231"}